Anomaly Detection in the Artificial Pancreas
|
|
|
- Clifton Lane
- 10 years ago
- Views:
Transcription
1 INGAR Instituto de Desarrollo y Diseño Consejo Nacional de Investigaciones Científicas y Técnicas Universidad Tecnológica Nacional Anomaly Detection in the Artificial Pancreas Luis Ávila, Ernesto Martínez INGAR (CONICET-UTN), Avellaneda 3657, Santa Fe S3002 GJC, Argentina {avilaol, ecmarti}@santafe-conicet.gob.ar 18 th September 2013 CAIS º Congreso Argentino de Informática y Salud 18 al 20 de Septiembre de 2013 Universidad Nacional de Córdoba
2 Diabetes mellitus Artificial pancreas Faulty conditions Reference behavior Diabetes mellitus disease resulting from the impaired mechanism of insulin secretion from the pancreas In Type 1 Diabetes β-cells in the pancreas do not produce insulin (Insulin-dependent). In Type 2 Diabetes the cells in body do not utilize insulin properly (Insulin-independent). CAIS º Congreso Argentino de Informática y Salud 2/16
3 Diabetes mellitus Artificial pancreas Faulty conditions Reference behavior Artificial pancreas A safety-critical design of the artificial pancreas should guarantee fast detection of performance degradation! CAIS º Congreso Argentino de Informática y Salud 3/16
4 Diabetes mellitus Artificial pancreas Faulty conditions Reference behavior Faults and surprising events Unstable signal output, interference or poor calibration Dietary change, exercise, stress or pregnancy Changes due to constraint activation or tuning of control algorithm Obstruction of the infusion catheter or mechanical failures These drawbacks make clear the necessity for supervision of the control loop and early detection of performance degradation CAIS º Congreso Argentino de Informática y Salud 4/16
5 Diabetes mellitus Artificial pancreas Faulty conditions Specified behavior Specified (optimal) behavior Detection of performance degradation in the regulation loop can be achieved by defining an optimal specified behavior and comparing it with real measurements obtained through Continuous Glucose Monitoring. Assuming an optimal control policy is used to control the glucoseinsulin dynamics over time, a reference behavior allows making a conjecture on expected BG levels. Significant deviationsfrom optimal behavior are evidence of changes in properly functioning of one or more components of the AP. CAIS º Congreso Argentino de Informática y Salud 5/16
6 Patient model Error Grid Analysis Patient (stochastic) model Bergman s two-compartment model plus Ito s stochastic process to capture the patient variability using the variance parameter. ( ) + (, ) ( + )( + ) dg Gin t NHGB p3 I G p2ia p5 KM GX Gren = + dt V G ( K + G) V V G X M G G σε dt CGM sensors record values every 5 minutes Stochastic samples generated with an Ito s process CAIS º Congreso Argentino de Informática y Salud 6/16
7 Bayesian surprise Error Grid Analysis Error Grid Analysis An AP should be regularly tested to assess on-line if it is performing well. Many tools have been proposed to gauge accuracy of continuous glucose sensors. Clarke: accounts for the distance of the current method to a reference and gives significance to deviations from the desired behavior. Consensus: based on the expertise of a large panel of clinicians to solve the problem of discontinuities presented by Clarke EGA. Continuous: evaluate not only sensor accuracy in terms of correct presentation of BGL but also the direction and rate of BG fluctuations. CAIS º Congreso Argentino de Informática y Salud 7/16
8 Clarke s grid Clarke s grid PID and variability Closed-Loop EGA CL-EGA: variability CL-EGA: miscalibration It uses a Cartesian diagram where values estimated by the technique under scrutiny are displayed against the values provided by the reference method The diagonal line represents perfect agreement between the two readings. Points below and above the 45º line indicate over and underestimation of BG values. Region A: accuracy with respect to the reference. Region B: benign deviations. Region C: inadequate treatment. Region D: failure to detect hypo- or hyperglycemia. Region E: confusion of needed treatment. CAIS º Congreso Argentino de Informática y Salud 8/16
9 Clarke s grid PID and variability Closed-Loop EGA CL-EGA: variability CL-EGA: miscalibration PID and variability Specified vs PID σ=0.10 Specified vs PID σ=0.50 CAIS º Congreso Argentino de Informática y Salud 9/16
10 Closed-Loop EGA Avoiding hypoglycemia is the most important issue! Clarke s grid PID and variability Closed-Loop EGA CL-EGA: variability CL-EGA: miscalibration Through adaptation, the Consensusgrid can be used to assess an AP performance. y-axis:bgl when the loop behaves optimally. x-axis:bgl for current dynamics. Optimal control should guarantee normoglycemia, reference is limited between 70 and 180 mg/dl. CAIS º Congreso Argentino de Informática y Salud 10/16
11 Clarke s grid PID and variability Closed-Loop EGA CL-EGA: variability CL-EGA: miscalibration CL-EGA: variability The modified CG-EGA assess pointand rateaccuracy Specified vs GPRL Closed loop performance for variability parameter σ=0.50. GPRL PID Specified vs PID CAIS º Congreso Argentino de Informática y Salud 11/16
12 Clarke s grid PID and variability Closed-Loop EGA CL-EGA: variability CL-EGA: miscalibration CL-EGA: miscalibration Assessment of closed loop performance using calibration parameter ξ=10%. Specified vs GPRL Specified vs PID CAIS º Congreso Argentino de Informática y Salud 12/16
13 Specified behavior Bayesian Surprise Specified behavior Developing an ability to rapidly detect surprising events is crucial in allowing safety critical systems to quickly identify potential risks and dangerous situations. The amount of surprise in new data from an AP by looking at the changes that take place in going from the specifiedto the current loop functioning CAIS º Congreso Argentino de Informática y Salud 13/16
14 Specified behavior Bayesian Surprise Bayesian Surprise Any deviation from specified operation accounts for a surprising event in the closed-loop functioning Assessment of variability σ=0.50. GPRL PID Fuzzy. P KL Surprisedescribes pointwise differences between the optimal and the current loop operation T KL Surprisedescribes a progressive shift in the closed-loop dynamics CAIS º Congreso Argentino de Informática y Salud 14/16
15 Summary Questions Summary Error Grid Analysis could be reused as a performance monitoring tool to detect glycemic variability and faulty conditions in an AP. We emphasize the importance of using well established methods in clinical practice to assess performance degradation. Our aim is to develop a generic on-line performance monitoring tool for the artificial pancreas that accounts for glycemic variability and faults using Bayesian inference. CAIS º Congreso Argentino de Informática y Salud 15/16
16 Summary Questions Questions CAIS º Congreso Argentino de Informática y Salud
A Fuzzy Controller for Blood Glucose-Insulin System
Journal of Signal and Information Processing, 213, 4, 111-117 http://dx.doi.org/1.4236/jsip.213.4215 Published Online May 213 (http://www.scirp.org/journal/jsip) 111 Ahmed Y. Ben Sasi 1, Mahmud A. Elmalki
Title: Using Formal Methods to Improve Safety of Home-Use Medical Devices
Title: Using Formal Methods to Improve Safety of Home-Use Medical Devices Authors: Ayan Banerjee Impact Lab, Arizona State University [email protected] Yi Zhang Center for Devices and Radiological Health,
Medical Policy Insulin Pumps
Medical Policy Insulin Pumps Document Number: 027 Authorization required Insulin Pumps & supplies Notification within 24 hours of service or next business day No Prior Authorization Not covered Pulsatile
Insulin dosage based on risk index of Postprandial Hypo- and Hyperglycemia in Type 1 Diabetes Mellitus with uncertain parameters and food intake
based on risk index of Postprandial Hypo- and Hyperglycemia in Type 1 Diabetes Mellitus with uncertain parameters and food intake Remei Calm 1, Maira García-Jaramillo 1, Jorge Bondia 2, Josep Vehí 1 1
[Frida Svendsen and Jennifer Southern] University of Oxford. October 2014
In adolescents with poorly controlled type 1 diabetes mellitus, could a bionic, bihormonal pancreas provide better blood glucose control than continuous subcutaneous insulin infusion therapy? [Frida Svendsen
Imagine a world... Believe in better control. MiniMed Veo Paradigm System Questions and Answers About Insulin Pumping
Imagine a world... Believe in better control MiniMed Veo Paradigm System Questions and Answers About Insulin Pumping 1 Imagine a world... Where you can exercise whenever you want and not have to carb load
Universita degli Studi di Padova Facolta di Ingegneria
Universita degli Studi di Padova Facolta di Ingegneria Finito di scrivere il giorno September 5, 01 utilizzando L A TEX ε UNIVERSITÀ DEGLI STUDI DI PADOVA FACOLTÀ DI INGEGNERIA Dipartimento di Ingegneria
Insulin Infusion Pumps
Medical Coverage Policy Insulin Infusion Pumps EFFECTIVE DATE: 09/01/2004 POLICY LAST UPDATED: 08/06/2013 OVERVIEW The policy addresses insulin infusion pumps that are worn externally and those that are
JDRF Type One Nation Research Summit Diabetes Technology: A Bridge to a Cure
JDRF Type One Nation Research Summit Diabetes Technology: A Bridge to a Cure Kelly L. Close, president, Close Concerns editor-in-chief, diatribe March 1, 2014 closeconcerns.com diatribe.org @diatribenews
X-Plain Hypoglycemia Reference Summary
X-Plain Hypoglycemia Reference Summary Introduction Hypoglycemia is a condition that causes blood sugar level to drop dangerously low. It mostly shows up in diabetic patients who take insulin. When recognized
Imagine a world... Believe in better control. MiniMed Veo Paradigm System
Imagine a world... Believe in better control MiniMed Veo Paradigm System 1 Imagine a world... Where you can exercise whenever you want and not have to carb load or worry about hypos. R Where you can eat
Algorithms for Glycemic Management of Type 2 Diabetes
KENTUCKY DIABETES NETWORK, INC. Algorithms for Glycemic Management of Type 2 Diabetes The Diabetes Care Algorithms for Type 2 Diabetes included within this document are taken from the American Association
Department Of Biochemistry. Subject: Diabetes Mellitus. Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage.
Department Of Biochemistry Subject: Diabetes Mellitus Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage. Diabetes mellitus : Type 1 & Type 2 What is diabestes mellitus?
An Improved PID Switching Control Strategy for Type 1 Diabetes
An Improved PID Switching Control Strategy for Type 1 Diabetes Gianni Marchetti, Massimiliano Barolo, Lois Jovanovic, Howard Zisser, and Dale E. Seborg, Member, IEEE Department of Chemical Engineering
Monitoring and Carbohydrate Counting: The Cornerstones of Diabetes Control. Linda Macdonald, M.D. November 19, 2008
Monitoring and Carbohydrate Counting: The Cornerstones of Diabetes Control Linda Macdonald, M.D. November 19, 2008 Objectives Understand the relationship between insulin, carbohydrate intake, and blood
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic
Insulin Pump Therapy and Continuous Glucose Sensor Use in the Management of Diabetes Mellitus
Insulin Pump Therapy and Continuous Glucose Sensor Use in the Management of Diabetes Mellitus Louis Haenel, IV, DO, FACOI, FACE Endocrinology Roper Hospital Charleston, SC Dr. Louis Haenel IV has disclosed
Alternative method for delivering insulin using continuous subcutaneous insulin infusion (CSII) open loop system
ISHP Spring CE Conference April 12, 2015 St. Luke s Medical Center Randi Lynn Griffiths, PharmD Clinical outpatient pharmacist Boise VA Medical Center Boise, Idaho Alternative method for delivering insulin
Department of Pharmacy, Kaiser Permanente San Francisco Medical Center, San Francisco 94115, California, USA
Journal of Pharmacy and Pharmacology 3 (2015) 33-38 doi: 10.17265/2328-2150/2015.01.005 D DAVID PUBLISHING Evaluation of Glycemic Control with a Pharmacist-Managed Post-Cardiothoracic Surgery Insulin Protocol
WHY THE IMPLANTABLE INSULIN PUMP WORKS SO WELL
WHY THE IMPLANTABLE INSULIN PUMP WORKS SO WELL H ave you ever wondered why it is so very difficult to manage your diabetes? There is no lack of motivation - we know how important good control is, and we
Supplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Haidar A, Legault L, Matteau-Pelletier L, et
Managing Diabetes in the School Setting. Alabama State Department of Education Alabama Board of Nursing
Managing Diabetes in the School Setting Alabama State Department of Education Alabama Board of Nursing Diabetes Mellitus: Type I Diabetes Previously called Insulin-dependent or Juvenile Onset Diabetes
Taking Insulin Pumps to School. Rachel Calendo, MS, RN, CPNP, CDE, Martha Cuevas, RN, BSN, CPT
Taking Insulin Pumps to School Rachel Calendo, MS, RN, CPNP, CDE, Martha Cuevas, RN, BSN, CPT Insulin Pumps Today A micro-computer, about the size of a pager Programmed to deliver both a preset amount
ARTICLE IN PRESS Biomedical Signal Processing and Control xxx (2012) xxx xxx
Biomedical Signal Processing and Control xxx (2012) xxx xxx Contents lists available at SciVerse ScienceDirect Biomedical Signal Processing and Control journa l h omepage: www.elsevier.com/locate/bspc
4/7/2015 CONFLICT OF INTEREST DISCLOSURE OBJECTIVES. Conflicts of Interest None Heather Rush. Heather M. Rush, APRN, CDE Louisville, KY
Heather M. Rush, APRN, CDE Louisville, KY CONFLICT OF INTEREST DISCLOSURE Conflicts of Interest None Heather Rush A conflict of interest exists when an individual is in a position to profit directly or
Overview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health
Overview of Diabetes Management By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health Objectives: Describe the pathophysiology of diabetes. From a multiorgan systems viewpoint. Identify the types of diabetes.
Diabetes Medications: Insulin Therapy
Diabetes Medications: Insulin Therapy Courtesy Univ Texas San Antonio Eric L. Johnson, M.D. Department of Family and Community Medicine Diabetes and Insulin Type 1 Diabetes Autoimmune destruction of beta
Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner
Challenges in Glycemic Control in Adult and Geriatric Patients Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner Provide an overview of diabetes prevalence; discuss challenges and barriers
Objectives PERINATAL INSULIN PUMPS: BASICS FOR NURSES. Historical Perspective. Insulin Pumps in Pregnancy. Insulin Pumps in the US
Objectives PERINATAL INSULIN PUMPS: BASICS FOR NURSES Jo M. Kendrick, APN BC, CDE [email protected] Describe indications and contraindications for insulin pump use in hospitalized patients Differentiate
Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT
1 Nutrition Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 2 Type 2 Diabetes: A Growing Challenge in the Healthcare Setting Introduction and background of type 2 diabetes:
Section 5: Type 2 Diabetes
SECTION OVERVIEW Definition and Symptoms Blood Glucose Monitoring Healthy Eating Physical Activity Oral Medication Insulin Sharps Disposal Definition and Symptoms Type 2 diabetes is occurring more frequently
Automatic Blood Glucose Control in Diabetes
Automatic Blood Glucose Control in Diabetes Marit Owren Master of Science in Engineering Cybernetics Submission date: June 29 Supervisor: Bjarne Anton Foss, ITK Norwegian University of Science and Technology
A guidebook for people with diabetes
A guidebook for people with diabetes This booklet is designed to supplement, not replace, your doctor s advice. Please consult your doctor if you have any questions about what you read. You ll learn how
Inpatient Treatment of Diabetes
Inpatient Treatment of Diabetes Alan J. Conrad, MD Medical Director Diabetes Services EVP, Physician Alignment Diabetes Symposium November 12, 2015 Objectives Explain Palomar Health goals for inpatient
Implications of Meal Library & Meal Detection to Glycemic Control of Type 1 Diabetes Mellitus through MPC Control
Proceedings of the 17th World Congress The International Federation of Automatic Control Seoul, Korea, July 6-11, 28 Implications of Meal Library & Meal Detection to Glycemic Control of Type 1 Diabetes
TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU
TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation
Diabetes mellitus. Lecture Outline
Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized
AN INTELLIGENT SUPPORT SYSTEM FOR DIABETIC PATIENTS
AN INTELLIGENT SUPPORT SYSTEM FOR DIABETIC PATIENTS Mark Hoogendoorn, Michel C. A. Klein, Nataliya M. Mogles VU University Amsterdam, Department of Artificial Intelligence, De Boelelaan 1081, Amsterdam,
Methods for Delivering Insulin and Monitoring Blood Sugar. A Review of the Research for Children, Teens, and Adults With Diabetes
Methods for Delivering Insulin and Monitoring Blood Sugar A Review of the Research for Children, Teens, and Adults With Diabetes Is This Information Right for Me? Yes, if: Your doctor* has told you that
Baskets of Care Diabetes Subcommittee
Baskets of Care Diabetes Subcommittee Disclaimer: This background information is not intended to be a comprehensive scientific discussion of the topic, but rather an attempt to provide a baseline level
Textbook: Chapter 12 pages 351-353, Chapter 13 pages 385-388
EXERCISE 11: BEDSIDE GLUCOSE TESTING Textbook: Chapter 12 pages 351-353, Chapter 13 pages 385-388 Skills: Objectives: 15 points 1. List the limitations of the bedside glucose test procedure. 2. State the
INTERNAL MEDICINE RESIDENTS NOON CONFERENCE: INPATIENT GLYCEMIC CONTROL
INTERNAL MEDICINE RESIDENTS NOON CONFERENCE: INPATIENT GLYCEMIC CONTROL Presented by: Leyda Callejas PGY5 Endocrinology, Diabetes and Metabolism Acknowledgements: Dr. P Orlander Dr. V Lavis Dr. N Shah
Get Primed on Pumps: A beginners guide to Insulin Pump Therapy
Get Primed on Pumps: A beginners guide to Insulin Pump Therapy Advantages of insulin pump therapy There are many advantages to using an insulin pump. Anyone can do it with the right training and support.
Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)
Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:
CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus
CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing
Teledermatology: an experience in Tucumán
Teledermatology: an experience in Tucumán V. I. Rotger1, P. F. Solarz2, L. M. Ruiz2,3, A. Salas2, M. C. García Mena, J. M. Olivera1 1 Departamento de Bioingeniería, Fac. de Cs Exactas y Tecnología, Universidad
Insulin Delivery Options: Inhale, Inject, and Infuse. Traci Evans, A.N.P., B.C.-A.D.M. Nurse Practitioner The Diabetes Center Ocean Springs, MS
Insulin Delivery Options: Inhale, Inject, and Infuse Traci Evans, A.N.P., B.C.-A.D.M. Nurse Practitioner The Diabetes Center Ocean Springs, MS Objectives Identify three ways patients are able to utilize
Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005
Cardiovascular Disease Risk Factors Part XII By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 As we approach the end of our extended series on cardiovascular disease risk factors,
Pattern Recognition in Medical Images using Neural Networks. 1. Pattern Recognition and Neural Networks
Pattern Recognition in Medical Images using Neural Networks Lic. Laura Lanzarini 1, Ing. A. De Giusti 2 Laboratorio de Investigación y Desarrollo en Informática 3 Departamento de Informática - Facultad
Basal and Bolus Insulin 7/16/2014. Jackie Aday RN, BSN, CDE Jeni Neighbors RN, BSN, CDE. BASAL: Small amount of insulin infused every few minutes
Jackie Aday RN, BSN, CDE Jeni Neighbors RN, BSN, CDE Insulin Pump Therapy Open looped system in which a small amount of insulin is continuously infused through a cannula or needle (basal rate) Larger doses
Medical Coverage Policy Glucose Monitoring Systems sad
Medical Coverage Policy Glucose Monitoring Systems sad EFFECTIVE DATE: 03 03 2009 POLICY LAST UPDATED: 01 17 2012 OVERVIEW This policy addresses several methods of monitoring blood glucose: the glucometer,
Criteria: CWQI HCS-123 (This criteria is consistent with CMS guidelines for External Infusion Insulin Pumps)
Moda Health Plan, Inc. Medical Necessity Criteria Subject: Origination Date: 05/15 Revision Date(s): 05/2015 Developed By: Medical Criteria Committee 06/24/2015 External Infusion Insulin Pumps Page 1 of
MEDICAL COVERAGE POLICY. SERVICE: Insulin Pump and Continuous Glucose Monitoring. PRIOR AUTHORIZATION: Required. POLICY:
Important note Even though this policy may indicate that a particular service or supply may be considered covered, this conclusion is not based upon the terms of your particular benefit plan. Each benefit
Insulin Pump Therapy. Jen Block, MSN, RN, CDE Stanford University Department of Pediatric Endocrinology
Insulin Pump Therapy Jen Block, MSN, RN, CDE Stanford University Department of Pediatric Endocrinology Disclosures Member of Clinical Advisory Panel for Tandem Work on a variety of clinical trials funded
BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS
BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS C O N T A C T D I A B E T E S S E R V I C E S F O R M O R E I N F O R M A T I O N 8 4 7-9 1 7-6 9 0 7 THIS SLIDE PRESENTATION WAS PREPARED BY SUE DROGOS,
Clinical Validity of Insulin Bolus Calculators
Clinical Validity of Insulin Bolus Calculators Howard A. Wolpert, MD Senior Physician, Joslin Diabetes Center Associate Professor, Harvard Medical School Director, Joslin Institute for Technology Translation
The What, Why, Who & How of Insulin Pumps. Bridget Lydon May 2014
The What, Why, Who & How of Insulin Pumps Bridget Lydon May 2014 Topics WHAT is an insulin pump HOW a pump works WHY use a pump WHO should use a pump Pharmac criteria for funded pumps All began back in
Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University
Tuberculosis And Diabetes Dr. hanan abuelrus Prof.of internal medicine Assiut University TUBERCULOSIS FACTS More than 9 million people fall sick with tuberculosis (TB) every year. Over 1.5 million die
HOW TO CARE FOR A PATIENT WITH DIABETES
HOW TO CARE FOR A PATIENT WITH DIABETES INTRODUCTION Diabetes is one of the most common diseases in the United States, and diabetes is a disease that affects the way the body handles blood sugar. Approximately
1333 Plaza Blvd, Suite E, Central Point, OR 97502 * www.mountainviewvet.net
1333 Plaza Blvd, Suite E, Central Point, OR 97502 * www.mountainviewvet.net Diabetes Mellitus (in cats) Diabetes, sugar Affected Animals: Most diabetic cats are older than 10 years of age when they are
SARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE CARE OF THE INTRAPARTUM PATIENT RECEIVING CONTINUOUS INTRAVENOUS INSULIN ADMINISTRATION (obs25) DATE: REVIEWED: PAGES: 9/93 8/15 1 of 7 PS1094 ISSUED
GESTATIONAL DIABETES. Diabete Gestazionale (Lingua Inglese)
GESTATIONAL DIABETES Diabete Gestazionale (Lingua Inglese) CONTENTS DEFINITION 03 WHAT CAUSES AND HOW TO MANAGE GESTATIONAL DIABETES 04 HOW TO CONTROL DIABETES 06 CORRECT LIFESTYLE 08 DURING AND AFTER
External Insulin Pumps Corporate Medical Policy
External Insulin Pumps Corporate Medical Policy File name: External Insulin Pumps File code: UM.DME.02 Origination: 4/2006 Last Review: 02/2014 (ICD-10 remediation only) Next Review: 10/2014 Effective
Glucose-Insulin System based on Minimal Model: a Realistic Approach
2015 17th UKSIM-AMSS International Conference on Modelling and Simulation Glucose-Insulin System based on Minimal Model: a Realistic Approach Adriana Aguilera González, Holger Voos Interdisciplinary Centre
NCT00272090. sanofi-aventis HOE901_3507. insulin glargine
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: Generic drug name:
2. What Should Advocates Know About Diabetes? O
2. What Should Advocates Know About Diabetes? O ften a school district s failure to properly address the needs of a student with diabetes is due not to bad faith, but to ignorance or a lack of accurate
glucose and fatty acids to raise your blood sugar levels.
Endocrine & Cell Communication Part IV: Maintaining Balance (Homeostasis) TEACHER NOTES needs coding 1 Endocrine & Cell Communication Part IV: Maintaining Balance (Homeostasis) 2 AP Biology Curriculum
US Diabetic Devices Industry Research Report: KenResearch
US Diabetic Devices Industry Research Report: KenResearch by KenResearch - Monday, February 24, 2014 https://www.kenresearch.com/blog/2014/02/us-diabetic-devices-industry-research-report-kenresearch/ The
tips Insulin Pump Users 1 Early detection of insulin deprivation in continuous subcutaneous 2 Population Study of Pediatric Ketoacidosis in Sweden:
tips Top International Publications Selection Insulin Pump Users Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated Patients with TD Population Study of Pediatric
Gayle Curto, RN, BSN, CDE Clinical Coordinator
Gayle Curto, RN, BSN, CDE Clinical Coordinator INTRODUCTION Historical Program Overview Leadership Team Mission Statement Diabetes Center Demographics for 2011 Older Adult Population HISTORICAL PROGRAM
The Joint Commission Advanced DSC Certification for Inpatient Diabetes Care
The Joint Commission Advanced DSC Certification for Inpatient Diabetes Care November 12, 2013 Caroline Isbey RN, MSN, CDE Associate Director Teresa Gomez Associate Project Director Specialist-SSM Carol
Diabetes Education Information for Teachers and School staff
Diabetes Education Information for Teachers and School staff The information below is intended to educate school staff on the basics of diabetes care. If you have a student in your classroom or you will
There seem to be inconsistencies regarding diabetic management in
Society of Ambulatory Anesthesia (SAMBA) Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Review of the consensus statement and additional
Causes, incidence, and risk factors
Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,
Diabetes Care 36:801 809, 2013
Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Clinical Evaluation of a Personalized Artificial Pancreas EYAL DASSAU, PHD 1,2,3 HOWARD ZISSER, MD 1,3 REBECCA A. HARVEY,
DIABETIC EDUCATION MODULE ONE GENERAL OVERVIEW OF TREATMENT AND SAFETY
DIABETIC EDUCATION MODULE ONE GENERAL OVERVIEW OF TREATMENT AND SAFETY First Edition September 17, 1997 Kevin King R.N., B.S., C.C.R.N. Gregg Kunder R.N., B.S.N., C.C.T.C. 77-120 CHS UCLA Medical Center
CLOSED LOOP MODEL FOR GLUCOSE INSULIN REGULATION SYSTEM USING LABVIEW
CLOSED LOOP MODEL FOR GLUCOSE INSULIN REGULATION SYSTEM USING LABVIEW 1 P Srinivas 2 P.Durga Prasada Rao 1 Associate Professor, Department of EIE, VR Siddhartha Engineering College, Vijayawada, India Email:
The Family Library. Understanding Diabetes
The Family Library Understanding Diabetes What is Diabetes? Diabetes is caused when the body has a problem in making or using insulin. Insulin is a hormone secreted by the pancreas and is needed for the
Glycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol
Glycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol Ruth LaCasse Kalish, RPh Department of Pharmacy Objectives Review the current practice at UConn Health with sliding
Type 1 Diabetes - Managing a Critical Ratio
Objectives Students will learn about how ratios and proportions are a key part of managing Type 1 Diabetes Students will learn about the regulation of blood glucose through insulin (hormone) binding with
Faculty. Program Objectives. Introducing the Problem. Diabetes is a Silent Killer. Minorities at Greater Risk of Having Type 2 Diabetes
Diabetes: The Basics Understanding and Managing Diabetes (Part 1 of 3) Satellite Conference Tuesday, October 18, 2005 2:00-4:00 p.m. (Central Time) Produced by the Alabama Department of Public Health Video
A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or
A Simplified Approach to Initiating Insulin When to Start Insulin: 1. Fasting plasma glucose (FPG) levels >250 mg/dl or 2. Glycated hemoglobin (A1C) >10% or 3. Random plasma glucose consistently >300 mg/dl
Glucose Management University of Colorado Hospital
Glucose Management University of Colorado Hospital Bridget Everhart, MSN, NP, CDE Inpatient Diabetes Educator [email protected] M F Pager 303 266-7898 UCH Diabetes Program Michael McDermott MD Diabetes
X-Plain Diabetes - Introduction Reference Summary
X-Plain Diabetes - Introduction Reference Summary Introduction Diabetes is a disease that affects millions of Americans every year. Your doctor may have informed you that you have diabetes. Although there
